Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pulmonx (LUNG) Change in Taxes (2019 - 2025)

Historic Change in Taxes for Pulmonx (LUNG) over the last 7 years, with Q3 2025 value amounting to -$7000.0.

  • Pulmonx's Change in Taxes fell 45000.0% to -$7000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $67000.0, marking a year-over-year decrease of 5037.04%. This contributed to the annual value of -$38000.0 for FY2024, which is 15588.24% down from last year.
  • As of Q3 2025, Pulmonx's Change in Taxes stood at -$7000.0, which was down 45000.0% from $68000.0 recorded in Q2 2025.
  • Pulmonx's 5-year Change in Taxes high stood at $155000.0 for Q4 2023, and its period low was -$148000.0 during Q2 2022.
  • For the 5-year period, Pulmonx's Change in Taxes averaged around $705.88, with its median value being -$2000.0 (2022).
  • As far as peak fluctuations go, Pulmonx's Change in Taxes skyrocketed by 210000.0% in 2023, and later crashed by 45000.0% in 2025.
  • Pulmonx's Change in Taxes (Quarter) stood at $108000.0 in 2021, then increased by 24.07% to $134000.0 in 2022, then grew by 15.67% to $155000.0 in 2023, then crashed by 111.61% to -$18000.0 in 2024, then surged by 61.11% to -$7000.0 in 2025.
  • Its Change in Taxes stands at -$7000.0 for Q3 2025, versus $68000.0 for Q2 2025 and $24000.0 for Q1 2025.